TSPO as a target for treatments of diseases, including neuropathological disorders.
about
Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic LigandsClassical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain diseaseTranslocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).
P2860
TSPO as a target for treatments of diseases, including neuropathological disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
TSPO as a target for treatments of diseases, including neuropathological disorders.
@en
TSPO as a target for treatments of diseases, including neuropathological disorders.
@nl
type
label
TSPO as a target for treatments of diseases, including neuropathological disorders.
@en
TSPO as a target for treatments of diseases, including neuropathological disorders.
@nl
prefLabel
TSPO as a target for treatments of diseases, including neuropathological disorders.
@en
TSPO as a target for treatments of diseases, including neuropathological disorders.
@nl
P2093
P2860
P356
P1476
TSPO as a target for treatments of diseases, including neuropathological disorders.
@en
P2093
P2860
P356
10.1038/CDDIS.2015.294
P577
2015-10-15T00:00:00Z